Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 28th January 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

IVC Evidensia reported to be planning £10bn London float
IVC Evidensia is one of Europe's largest veterinary care providers.
Veterinary group could enter the FTSE-100 index.

IVC Evidensia is set to launch a London float valued up to £10bn, according to media reports.

The float, expected to be unveiled in March, could reportedly see the Nestle-backed veterinary group enter the FTSE-100 index. According to Sky News, IVC has appointed Goldman Sachs and Jeffries to work on the listing. 

EQT, the Stockholm-based private equity firm which backs IVC, is also said to be assessing other options, such as a trade sale of the business or the private sale of a further stake to an external investor. 

IVC Evidensia is one of Europe's largest veterinary care providers, with a network of clinics, hospitals and out-of-hours centres spanning 11 countries. The group was formed in 2017 when Independent Vet Care merged with Evidensia, a Swedish-based firm also owned by EQT. 

IVC Evidensia entered into a partnership with Nestlé Purina PetCare in 2019. It currently has more than 19,000 employees.

IVC Evidensia has been contacted for comment.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'